Standard Chemical & Pharmaceutical Co., Ltd. — Investor Relations & Filings
Standard Chemical & Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical manufacturer established in 1967. The company specializes in the research, development, production, and marketing of a wide range of pharmaceutical products, including generic Western medicines, Active Pharmaceutical Ingredients (APIs), and healthcare supplements. Its therapeutic portfolio covers diverse areas such as cardiovascular, metabolic, respiratory, anti-infective, and musculoskeletal systems, as well as dermatological and urogenital treatments. As a prominent generic drug manufacturer, the company operates with an integrated business model that spans from high-tech R&D to brand management and distribution. Adhering to international quality standards and ISO 9001 certification, it focuses on technological innovation and sustainable growth to serve diverse healthcare needs across domestic and international markets.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 公告董事會決議股利分派事宜 | 2026-02-24 | Chinese | |
| 114年度股利金額(董事會決議) | 2026-02-24 | Chinese | |
| 公告本公司董事會決議召開115年股東常會事宜 | 2026-02-24 | Chinese | |
| 公告本公司董事會決議盈餘轉增資發行新股 | 2026-02-24 | Chinese | |
| 公告本公司董事會通過設置永續長 | 2026-02-24 | Chinese | |
| 代子公司「江蘇生達生技醫藥有限公司」公告資金貸與 超限改善計畫執行情形 | 2026-02-24 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 33437953 | 公告董事會決議股利分派事宜 | 2026-02-24 | Chinese | ||
| 33437956 | 114年度股利金額(董事會決議) | 2026-02-24 | Chinese | ||
| 33437958 | 公告本公司董事會決議召開115年股東常會事宜 | 2026-02-24 | Chinese | ||
| 33437962 | 公告本公司董事會決議盈餘轉增資發行新股 | 2026-02-24 | Chinese | ||
| 33437965 | 公告本公司董事會通過設置永續長 | 2026-02-24 | Chinese | ||
| 33437968 | 代子公司「江蘇生達生技醫藥有限公司」公告資金貸與 超限改善計畫執行情形 | 2026-02-24 | Chinese | ||
| 33437971 | 公告董事會通過114年第四季合併財務報告 | 2026-02-24 | Chinese | ||
| 33437975 | 公告本公司民國114年第四季財務報告 董事會預計召開日期為115年02月24日 | 2026-02-12 | Chinese | ||
| 33437980 | 115年1月背書保證與資金貸與 | 2026-02-09 | Chinese | ||
| 33437978 | 115年1月營業收入 | 2026-02-09 | Chinese | ||
| 33437985 | 115年01月董事會成員及持股 | 2026-02-09 | Chinese | ||
| 33437983 | 115年01月內部人持股異動(事後) | 2026-02-09 | Chinese | ||
| 33437990 | 114年12月背書保證與資金貸與 | 2026-01-09 | Chinese | ||
| 33437987 | 114年12月營業收入 | 2026-01-09 | Chinese | ||
| 33437995 | 114年12月內部人持股異動(事後) | 2026-01-02 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Standard Chemical & Pharmaceutical Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/51900/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=51900 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=51900 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=51900 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 51900}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Standard Chemical & Pharmaceutical Co., Ltd. (id: 51900)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.